| Item Type | Name |
|
Concept
|
Prospective Studies
|
|
Academic Article
|
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
|
|
Academic Article
|
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
|
|
Academic Article
|
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
|
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
|
Academic Article
|
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
|
|
Academic Article
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
|
|
Academic Article
|
Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
|
|
Academic Article
|
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
|
|
Academic Article
|
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
|
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
|
Academic Article
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
|
Academic Article
|
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
|
|
Academic Article
|
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
|
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
|
Academic Article
|
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
|
|
Academic Article
|
Presentation and outcomes with clinically apparent interferon beta hepatotoxicity.
|
|
Academic Article
|
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
|
|
Academic Article
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
|
Academic Article
|
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
|
|
Academic Article
|
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
|
|
Academic Article
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
|
|
Academic Article
|
Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
|
|
Academic Article
|
Amoxicillin-Clavulanate-Induced Liver Injury.
|
|
Academic Article
|
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
|
|
Grant
|
Research Network for Drug-Induced Liver Disease
|
|
Academic Article
|
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
|